Product How it works Pricing Blog FAQ About Contact
CRH

CRH (NYSE: CRH) financial statements

The consolidated income statement, balance sheet and cash flow statement of CRH for its last 4 fiscal years, as filed with the regulator, in millions of US dollars. At the end of fiscal 2025 it had $58,329m in total assets and $24,004m in equity.

Income statement

Item2025202420232022
Revenue$37,447m$35,572m$34,949m$32,723m
Cost of sales$23,919m$22,871m$22,986m$21,908m
Gross profit$13,528m$12,701m$11,963m$10,815m
Operating profit$5,440m$4,925m$4,186m$3,809m
Finance costs$810.0m$612.0m$376.0m$344.0m
Profit before tax$4,805m$4,714m$4,014m$3,461m
Income tax$1,041m$1,085m$925.0m$762.0m
Net profit$3,753m$3,492m$3,178m$3,862m
Earnings per share$5.54$5.06$4.36$5.15
Diluted earnings per share$5.51$5.02$4.33$5.11
Depreciation and amortisation$2,156m$1,798m$1,633m$1,577m

Balance sheet

Item2025202420232022
Total assets$58,329m$50,613m$47,469m$45,319m
Current assets$15,254m$14,083m$16,885m$14,833m
Inventories$5,251m$4,755m$4,291m$4,194m
Property, plant and equipment$24,937m$21,452m$17,841m$17,768m
Goodwill$13,099m$11,061m$9,158m$9,199m
Cash$4,096m$3,720m$6,341m$5,936m
Total liabilities$32,851m$27,763m$25,848m$22,279m
Current liabilities$8,754m$10,296m$10,013m$8,041m
Equity$24,004m$21,607m$20,854m$22,157m
Equity including minorities$25,048m$22,466m$21,288m$22,732m
Minority interests$1,044m$859.0m$434.0m$575.0m

Cash flow statement

Item2025202420232022
Operating cash flow$5,625m$4,989m$5,017m$3,800m
Investing cash flow−$6,045m−$6,291m−$2,391m−$917.0m
Financing cash flow$596.0m−$1,186m−$2,380m−$2,499m
Capital expenditure−$2,713m−$2,578m−$1,817m−$1,523m

Where each figure comes from

From the annual report (Form 10-K) that CRH files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022. If an item is not tagged in the filing, it is not in the table. The summary of the last fiscal year is on the CRH page.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.